Financials Establishment Labs Holdings Inc.

Equities

ESTA

VGG312491084

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
48.47 USD -0.14% Intraday chart for Establishment Labs Holdings Inc. +2.30% +87.22%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 569.8 882.2 1,622 1,598 668.2 1,331 - -
Enterprise Value (EV) 1 569.8 847.5 1,621 1,598 668.2 1,528 1,532 1,502
P/E ratio -14.9 x -23.1 x -39.3 x -21.3 x -8.43 x -27.9 x -67.3 x 174 x
Yield - - - - - - - -
Capitalization / Revenue 6.36 x 10.4 x 12.8 x 9.88 x 4.05 x 7.37 x 5.47 x 4.3 x
EV / Revenue 6.36 x 10 x 12.8 x 9.88 x 4.05 x 8.46 x 6.3 x 4.85 x
EV / EBITDA - -34.5 x -75.7 x -44.7 x -11 x -119 x 136 x 36 x
EV / FCF - - - -29 x - -50.9 x 76.6 x 27.3 x
FCF Yield - - - -3.44% - -1.96% 1.31% 3.66%
Price to Book - 11.7 x 32 x - - - - -
Nbr of stocks (in thousands) 20,601 23,438 24,004 24,342 25,808 27,460 - -
Reference price 2 27.66 37.64 67.59 65.65 25.89 48.47 48.47 48.47
Announcement Date 3/16/20 3/10/21 3/1/22 2/27/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 89.56 84.68 126.7 161.7 165.2 180.5 243.3 309.5
EBITDA 1 - -24.57 -21.42 -35.79 -60.86 -12.79 11.27 41.67
EBIT 1 -30.94 -27.92 -25.14 -39.66 -65.03 -26.18 -2.76 21.85
Operating Margin -34.55% -32.97% -19.84% -24.53% -39.37% -14.5% -1.13% 7.06%
Earnings before Tax (EBT) 1 -37.51 -38.02 -39.71 -72.82 -78.58 -45.9 -19.33 8.727
Net income 1 -38.15 -38.12 -41.14 -75.21 -78.5 -47.35 -19.74 7.547
Net margin -42.59% -45.02% -32.47% -46.51% -47.53% -26.23% -8.12% 2.44%
EPS 2 -1.860 -1.630 -1.720 -3.080 -3.070 -1.736 -0.7198 0.2783
Free Cash Flow 1 - - - -55.02 - -30 20 55
FCF margin - - - -34.02% - -16.62% 8.22% 17.77%
FCF Conversion (EBITDA) - - - - - - 177.52% 132%
FCF Conversion (Net income) - - - - - - - 728.76%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/16/20 3/10/21 3/1/22 2/27/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 29.04 35.31 38.45 41.19 38.24 43.81 46.52 48.56 38.51 31.56 35.54 43.89 48.09 52.87 53.62
EBITDA 1 -8.096 -8.44 -4.622 -9.45 -9.539 -12.17 -7.224 -12.58 -19.98 -20.89 -10.03 -2.381 -1.169 0.8142 -1.1
EBIT 1 -9.044 -9.366 -5.575 -10.41 -10.52 -13.16 -8.16 -13.71 -21.04 -22.12 -13.39 -6.305 -4.397 -2.042 -2.3
Operating Margin -31.14% -26.52% -14.5% -25.26% -27.5% -30.04% -17.54% -28.24% -54.64% -70.07% -37.66% -14.37% -9.14% -3.86% -4.29%
Earnings before Tax (EBT) 1 -14.61 -13.4 -5.534 -36.54 -18 -12.74 -11.11 -15.82 -28.6 -23.05 -18.34 -11.09 -9.664 -6.758 -6.3
Net income 1 -14.68 -14.19 -5.933 -37.11 -18.61 -13.56 -11.94 -16.74 -29.27 -20.54 -18.8 -11.44 -9.997 -7.075 -6.7
Net margin -50.55% -40.19% -15.43% -90.08% -48.65% -30.95% -25.67% -34.48% -76.02% -65.09% -52.9% -26.06% -20.79% -13.38% -12.49%
EPS 2 -0.6100 -0.5900 -0.2400 -1.520 -0.7600 -0.5500 -0.4800 -0.6500 -1.120 -0.7900 -0.6684 -0.4183 -0.3786 -0.2743 -0.2200
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/9/21 3/1/22 5/9/22 8/8/22 11/7/22 2/27/23 5/8/23 8/8/23 11/7/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 197 201 171
Net Cash position 1 - 34.7 1.51 - - - - -
Leverage (Debt/EBITDA) - - - - - -15.4 x 17.84 x 4.104 x
Free Cash Flow 1 - - - -55 - -30 20 55
ROE (net income / shareholders' equity) - -50.9% -65.5% - - -154% -68.4% -22.7%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - 3.210 2.110 - - - - -
Cash Flow per Share - - - -2.130 - - - -
Capex 1 - 2.42 2.43 2.85 - 20 18 22
Capex / Sales - 2.86% 1.91% 1.76% - 11.08% 7.4% 7.11%
Announcement Date 3/16/20 3/10/21 3/1/22 2/27/23 2/28/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
48.47 USD
Average target price
59.29 USD
Spread / Average Target
+22.31%
Consensus
  1. Stock Market
  2. Equities
  3. ESTA Stock
  4. Financials Establishment Labs Holdings Inc.